BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25233992)

  • 1. Autoimmune disease: Getting to the root of hair loss in alopecia.
    Bray N
    Nat Rev Drug Discov; 2014 Oct; 13(10):724-5. PubMed ID: 25233992
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibiting Janus kinases to treat alopecia areata.
    Divito SJ; Kupper TS
    Nat Med; 2014 Sep; 20(9):989-90. PubMed ID: 25198048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition.
    Xing L; Dai Z; Jabbari A; Cerise JE; Higgins CA; Gong W; de Jong A; Harel S; DeStefano GM; Rothman L; Singh P; Petukhova L; Mackay-Wiggan J; Christiano AM; Clynes R
    Nat Med; 2014 Sep; 20(9):1043-9. PubMed ID: 25129481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata.
    Blume-Peytavi U; Vogt A
    EBioMedicine; 2015 Apr; 2(4):282-3. PubMed ID: 26137570
    [No Abstract]   [Full Text] [Related]  

  • 5. Alopecia Areata: a Comprehensive Review of Pathogenesis and Management.
    Trüeb RM; Dias MFRG
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):68-87. PubMed ID: 28717940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Janus Kinase Inhibitors against Other Biological Treatments in Alopecia Areata.
    Tavakolpour S
    Scand J Immunol; 2016 May; 83(5):345-6. PubMed ID: 26939767
    [No Abstract]   [Full Text] [Related]  

  • 7. Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib.
    Jabbari A; Dai Z; Xing L; Cerise JE; Ramot Y; Berkun Y; Sanchez GA; Goldbach-Mansky R; Christiano AM; Clynes R; Zlotogorski A
    EBioMedicine; 2015 Apr; 2(4):351-5. PubMed ID: 26137574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JAK Inhibitors for Treatment of Alopecia Areata.
    Wang EHC; Sallee BN; Tejeda CI; Christiano AM
    J Invest Dermatol; 2018 Sep; 138(9):1911-1916. PubMed ID: 30057345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alopecia areata is a T-lymphocyte mediated autoimmune disease: lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID mice.
    Gilhar A; Shalaginov R; Assy B; Serafimovich S; Kalish RS
    J Investig Dermatol Symp Proc; 1999 Dec; 4(3):207-10. PubMed ID: 10674367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alopecia areata with autoimmune polyglandular syndrome type 3 showing type 1/Tc1 immunological inflammation.
    Hanai S; Ito T; Furuta T; Tokura Y
    Eur J Dermatol; 2020 Aug; 30(4):425-427. PubMed ID: 32969803
    [No Abstract]   [Full Text] [Related]  

  • 11. Alopecia areata: A multifactorial autoimmune condition.
    Simakou T; Butcher JP; Reid S; Henriquez FL
    J Autoimmun; 2019 Mar; 98():74-85. PubMed ID: 30558963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alopecia areata: a tissue specific autoimmune disease of the hair follicle.
    Gilhar A; Kalish RS
    Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New and Emerging Therapies for Alopecia Areata.
    Pourang A; Mesinkovska NA
    Drugs; 2020 May; 80(7):635-646. PubMed ID: 32323220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical Janus kinase inhibitors: A review of applications in dermatology.
    Hosking AM; Juhasz M; Mesinkovska NA
    J Am Acad Dermatol; 2018 Sep; 79(3):535-544. PubMed ID: 29673776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perinevoid alopecia: a case report and literature review.
    Kimura H; Nagase K; Narisawa Y
    Br J Dermatol; 2018 Oct; 179(4):969-970. PubMed ID: 29704462
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of janus kinase inhibitors in the treatment of alopecia areata.
    Triyangkulsri K; Suchonwanit P
    Drug Des Devel Ther; 2018; 12():2323-2335. PubMed ID: 30100707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alopecia areata: current therapy.
    Fiedler VC
    J Invest Dermatol; 1991 May; 96(5):69S-70S. PubMed ID: 2022876
    [No Abstract]   [Full Text] [Related]  

  • 18. SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction.
    Gao Z; Jin YQ; Wu W
    Oncotarget; 2017 May; 8(20):33432-33443. PubMed ID: 28418931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib.
    Cheng MW; Kehl A; Worswick S; Goh C
    J Drugs Dermatol; 2018 Jul; 17(7):800-803. PubMed ID: 30005104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice.
    Gilhar A; Ullmann Y; Berkutzki T; Assy B; Kalish RS
    J Clin Invest; 1998 Jan; 101(1):62-7. PubMed ID: 9421466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.